SCHEMBL30186793

SCHEMBL30186793

CC(C)(C)OC(=O)N1CCC(n2ccc3cc(Br)ccc3c2=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 3/20 0.46
▸ USP30 Q70CQ3 1/20 0.43
▸ BACE1 P56817 3/20 0.43
▸ HCAR1 Q9BXC0 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ PRKCG P05129 1/20 0.42
▸ PRKCB P05771 1/20 0.42
▸ PRKCA P17252 1/20 0.42
▸ PRKCH P24723 1/20 0.42
▸ PRKCE Q02156 1/20 0.42
▸ PRKCD Q05655 1/20 0.42
▸ GPR119 Q8TDV5 5/20 0.41
▸ TP53 P04637 1/20 0.40
▸ PTPN2 P17706 1/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ PTPN6 P29350 1/20 0.40
▸ CTSD P07339 1/20 0.39
▸ CTSE P14091 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25151044 1.00 FPR2 (0.46) FPR2USP30BACE1HCAR1KDM4E
SCHEMBL30398712 0.88 FPR2 (0.49) FPR2USP30BACE1HCAR1MAPT
SCHEMBL18296156 0.88 FPR2 (0.49) FPR2USP30BACE1HCAR1MAPT
SCHEMBL4898807 0.86 USP30 (0.50) FPR2USP30BACE1HCAR1KDM4E
SCHEMBL25151663 0.85 HCAR1 (0.41) FPR2USP30HCAR1KDM4EMAPT
SCHEMBL25151017 0.85 PDE4B (0.43) FPR2BACE1HCAR1KDM4EMAPT
SCHEMBL30398878 0.85 HCAR1 (0.45) FPR2BACE1HCAR1KDM4EMAPT
SCHEMBL25339026 0.84 USP30 (0.52) FPR2USP30BACE1HCAR1KDM4E
SCHEMBL25151191 0.82 DPP4 (0.42) FPR2USP30BACE1HCAR1KDM4E
SCHEMBL25151052 0.82 STS (0.43) FPR2USP30HCAR1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4416141-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING Remix Therapeutics Inc. (US) 2024-08-21 — — EP disclosed
WO-2023064880-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING REMIX THERAPEUTICS INC. (US) 2023-04-20 — — WO disclosed
EP-4132646-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2023-02-15 — — EP disclosed
Send feedback